Results 81 to 90 of about 24,553 (208)

SER-109, an Investigational Microbiome Drug to Reduce Recurrence After Clostridioides difficile Infection: Lessons Learned From a Phase 2 Trial [PDF]

, 2020
Barbara McGovern, Christopher B. Ford, Matthew R. Henn, Darrell S. Pardi, Sahil Khanna, Elizabeth Hohmann, Edward J. O’Brien, Christopher A. Desjardins, Patricia Bernardo, Jennifer R. Wortman, Mary-Jane Lombardo, Kevin Litcofsky, Jonathan Winkler, Christopher McChalicher, Sunny S. Li, Amelia D. Tomlinson, Madhumitha Nandakumar, David N. Cook, Roger J. Pomerantz, John Auniņš, Michele Trucksis   +20 more
openalex   +1 more source

Consortium of Probiotics Attenuates Colonization of Clostridioides difficile

Frontiers in Microbiology, 2019
Clostridioides difficile infection (CDI) is increasing morbidity and mortality rates globally. Fecal microbiota transplantation (FMT), an effective therapy for eliminating Clostridioides difficile (C.
Xianping Li, Xianping Li, Qiongfang Chu, Qiongfang Chu, Qiongfang Chu, Yuanming Huang, Yuanming Huang, Yuchun Xiao, Yuchun Xiao, Liqiong Song, Liqiong Song, Siyi Zhu, Siyi Zhu, Ying Kang, Ying Kang, Shan Lu, Shan Lu, Jianguo Xu, Jianguo Xu, Zhihong Ren, Zhihong Ren   +20 more
doaj   +1 more source

Clostridioides difficile Infection in Chronic Kidney Disease—An Overview for Clinicians [PDF]

, 2021
Sylwia Dudzicz, Andrzej Więcek, Marcin Adamczak   +2 more
openalex   +1 more source

Pathogenicity locus determinants and toxinotyping of Clostridioides difficile isolates recovered from Iranian patients

New Microbes and New Infections, 2018
Little is known about the toxin profiles, toxinotypes and variations of toxin Clostridioides difficile C (tcdC) in Iranian C. difficile isolates. A total of 818 stool specimens were obtained from outpatients (n = 45) and hospitalized patients (n = 773 ...
A. Aliramezani, M. Talebi, A. Baghani, M. Hajabdolbaghi, M. Salehi, A. Abdollahi, S. Afhami, M. Marjani, F. Golbabaei, M.A. Boroumand, A. Sarrafnejad, M. Yaseri, S. Ghourchian, M. Douraghi   +13 more
doaj   +1 more source

Perils and pitfalls of probiotic quasi-experimental studies for primary prevention of Clostridioides difficile infection: A review of the evidence [PDF]

, 2020
Lynne V. McFarland, Stuart Johnson, Charlesnika T. Evans   +2 more
openalex   +1 more source

Improving Stewardship of Clostridioides difficile Testing with EMR and Provider Phone Calls

, 2022
Joseph Joslin, Elizabeth Ablah, Hayrettin Okut, Lauren Bricker, Maha Assi   +4 more
openalex   +2 more sources

Structural and functional insight into the interaction of Clostridioides difficile toxin B and FZD7

Cell Reports
Summary: The G protein-coupled receptors of the Frizzled (FZD) family, in particular FZD1,2,7, are receptors that are exploited by Clostridioides difficile toxin B (TcdB), the major virulence factor responsible for pathogenesis associated with ...
Julia Kinsolving, Julien Bous, Pawel Kozielewicz, Sara Košenina, Rawan Shekhani, Lukas Grätz, Geoffrey Masuyer, Yuankai Wang, Pål Stenmark, Min Dong, Gunnar Schulte   +10 more
doaj   +1 more source

Trends in Clostridioides difficile prevalence, mortality, severity, and age composition during 2003–2014, the national inpatient sample database in the US [PDF]

, 2022
Sun O. Park, Ilhwan Yeo
openalex   +1 more source

Curbing inappropriate C. difficile treatment in patients receiving concomitant laxatives

Antimicrobial Stewardship & Healthcare Epidemiology
In the setting of universal Clostridioides difficile screening, we implemented an alert that triggered when C. difficile treatment was ordered in patients who recently received laxatives. This resulted in C.
Paige Fields, Christopher David, Anish Choksi, Natasha N. Pettit, Alison K. Lew, Jennifer Pisano, Cynthia T. Nguyen   +6 more
doaj   +1 more source

Clostridioides difficile Testing Stewardship for Laxative Use Is Effective and Safe When Combined With Expert Clinical Input [PDF]

, 2020
Francesca J. Torriani, Frank Myers Robert El-Kareh, Minji Kang, Randy Taplitz, Shira R. Abeles   +4 more
openalex   +1 more source